| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.086 | 0.004 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.005 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.005 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.006 |